Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience.
Saved in:
| Title: | Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience. |
|---|---|
| Authors: | Wheler, J. J.1, Tsimberidou, A. M.1, Hong, D. S.1, Naing, A.1, Falchook, G. S.1, Fu, S.1, Moulder, S.1,2, Stephen, B.1, Wen, S.3, Kurzrock, R.1 |
| Source: | Annals of Oncology. Aug2012, Vol. 23 Issue 8, p1963-1967. 5p. 1 Chart, 1 Graph. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mds027 |
